Palladia (toceranib phosphate)
Palladia is an antiproliferative and antiandiogenic agent used to treat Patnaik grade II or III, cutaneous mast cell tumors in dogs.
This medication uses toceranic phosphate to combat the effects of these recurrent tumors and works on both tumors with and without regional lymph node involvement. Palladia can also be used as an alternative to chemotherapy for other various types of tumors, including melanomas, thyroid carcinomas, and more.
Palladia is available in 10 mg, 15 mg, and 50 mg tabs to ensure that adjusting your dog’s dosage based on their weight is a simple manner. Each dosage is available for purchase by the tab or in a container of 30 tabs.Key Features:Treats Patnaik grade II or III recurrent, cutaneous mast cell tumors in dogsCan be used as alternative to chemotherapy for other types of tumorsAvailable in three different dosages in singles doses or packs of 30Product Uses:Antiproliferative and antiangiogenic agentPrevents tissue inflammation caused by malignant tumorsInhibits tyrosine kinase, which kills the tumor cells directly and also interferes with the tumor’s blood supplyConditions:
Dosing:You should consult a veterinarian to determine the exact dosage that is appropriate for your petThe appropriate dosage will depend both on the size of your petDosage will be adjusted over time as neededMore information on dosing should be available in the prescription informationAdministration:Administer doses orally every other dayDose reductions and interruptions can be utilized as advised by your veterinarianYour veterinarian should make weekly assessments to determine any necessary adjustments to your pet’s dosageMay be administered with or without food- tablets are not to be split and should be administered wholeSide Effects:DiarrheaAppetite lossLamenessWeight lossBloody stool
- For the treatment of dogs with mast cell tumors
- An alternative to chemotherapy for other types of tumors, including:
- Squamous cell carcinoma
- Metastatic osteosarcoma
- Malignant Melanoma
- Anal sac adrenocarcinoma
- Vaccine Associated Fibrosarcoma
- Transitional Cell Carcinoma
- Thyroid Carcinoma